Cargando…
Insulin Receptor Isoforms in Cancer
The insulin receptor (IR) mediates both metabolic and mitogenic effects especially when overexpressed or in clinical conditions with compensatory hyperinsulinemia, due to the metabolic pathway resistance, as obesity diabetes. In many cancers, IR is overexpressed preferentially as IR-A isoform, deriv...
Autores principales: | Vella, Veronica, Milluzzo, Agostino, Scalisi, Nunzio Massimo, Vigneri, Paolo, Sciacca, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274710/ https://www.ncbi.nlm.nih.gov/pubmed/30453495 http://dx.doi.org/10.3390/ijms19113615 |
Ejemplares similares
-
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
por: Tumminia, Andrea, et al.
Publicado: (2021) -
Insulin Receptor Isoforms Differently Regulate Cell Proliferation and Apoptosis in the Ligand-Occupied and Unoccupied State
por: Massimino, Michele, et al.
Publicado: (2021) -
Insulin degludec in the first trimester of pregnancy: Report of two cases
por: Milluzzo, Agostino, et al.
Publicado: (2017) -
The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
por: Vella, Veronica, et al.
Publicado: (2018) -
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023)